GSK plc Adjustments For Decrease Increase In Trade Account Receivable
GSK plc (GSK) reported Adjustments For Decrease Increase In Trade Account Receivable of -GBP 613.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-06.
Financial Statements › Notes › Receivables
ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable · last filed 2026-03-06
| Period end | Adjustments For Decrease Increase In Trade Account Receivable 12 month | Adjustments For Decrease Increase In Trade Account Receivable 12 month as first filed |
|---|---|---|
| 2025-12-31 | -613.00M GBP 20-F · filed 2026-03-06 | |
| 2024-12-31 | 298.00M GBP 20-F · filed 2026-03-06 | |
| 2023-12-31 | -794.00M GBP 20-F · filed 2026-03-06 | |
| 2022-12-31 | -158.00M GBP 20-F · filed 2025-03-03 | |
| 2021-12-31 | -780.00M GBP 20-F · filed 2024-03-05 | -782.00M GBP 20-F · filed 2022-03-08 |
| 2020-12-31 | -279.00M GBP 20-F · filed 2023-03-10 | -224.00M GBP 20-F · filed 2021-03-12 |
| 2019-12-31 | -32.00M GBP 20-F · filed 2022-03-08 | |
| 2018-12-31 | -429.00M GBP 20-F · filed 2021-03-12 | |
| 2017-12-31 | -287.00M GBP 20-F · filed 2020-03-06 | |
| 2016-12-31 | -188.00M GBP 20-F · filed 2019-03-15 | |
| 2015-12-31 | 98.00M GBP 20-F/A · filed 2018-03-20 |